Characterization of signaling pathways that are regulated through cell surface molecular interaction in B cell lymphoma.
| Project/Area Number |
22790071
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Kochi University |
|---|
Principal Investigator |
KOTANI Norihiro 高知大学, 教育研究部・医療学系, 助教 (90342782)
|
|---|
| Research Collaborator |
HONKE Koichi 高知大学, 教育研究部・医療学系, 教授 (80190263)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 膜タンパク質 / 分子間相互作用 / Bリンパ腫細胞 / B細胞リンパ腫 |
|---|
| Research Abstract |
Many plasma membrane-resident proteins collaborate with other molecules by molecular interactions in a variety of biological events. Herein, we have studied interacted molecules associated with CD20-rituximab complex on B cell lymphoma cells. We found some cell surface molecules, such as FGFR3, HLA class II, and HSP-90 are interacted with CD20-rituximab complex. Above all, FGFR3 possibly plays important role for efficacy of rituximab-dependent cytotoxic effect through cell cycle signaling pathways.
|
Report
(3 results)
Research Products
(19 results)
